UB Paderborn / Katalog / Suche / in CDI

1 – 11 von 11

Sortiert nach

Analysis of CD117-negative gastrointestinal stromal tumors

World journal of gastroenterology : WJG, 2005-02, Vol.11 (7), p.1052

2005

Link zum Volltext

Verfügbarkeit prüfen

PIK3CA Exon 20 Mutation is Independently Associated with a Poor Prognosis in Breast Cancer Patients

Annals of surgical oncology, 2008-04, Vol.15 (4), p.1064-1069

2008

Link zum Volltext

Verfügbarkeit prüfen

Identification of Human-Specific Adaptation Sites of ATP6

Annals of the New York Academy of Sciences, 2005-05, Vol.1042 (1), p.142-147

2005

Link zum Volltext

Verfügbarkeit prüfen

ND4 mutation in transitional cell carcinoma: Does mitochondrial mutation occur before tumorigenesis?

Mitochondrion, 2007-07, Vol.7 (4), p.273-278

2007

Link zum Volltext

Verfügbarkeit prüfen

Mechanism-based inhibition of thioredoxin reductase by antitumor quinoid compounds

Biochemical pharmacology, 1992-04, Vol.43 (7), p.1613-1620

1992

Link zum Volltext

Verfügbarkeit prüfen

Analysis of disease-associated ND4 mutations: how do we know which mutation is pathogenic?

Mitochondrion, 2007-02, Vol.7 (1-2), p.151-156

2007

Link zum Volltext

Verfügbarkeit prüfen

Compliance of Clinical Trial Consent Forms with International Guidelines: Analysis of Deficiencies

Therapeutic innovation & regulatory science, 2002, Vol.36 (1), p.17-19

2002

Link zum Volltext

Verfügbarkeit prüfen

What Type of Pivotal Study Design is Appropriate for an Investigational New Drug to Manage Chronic Angle Closure Glaucoma: Active Control or Placebo?

Therapeutic innovation & regulatory science, 2002, Vol.36 (3), p.499-500

2002

Link zum Volltext

Verfügbarkeit prüfen

Inhibition Of Thioredoxin Reductase (E.C. 1.6.4.5.) By Antitumor Quinones

Free radical research, 1990, Vol.8 (4-6), p.365-372

1990

Link zum Volltext

Verfügbarkeit prüfen

Inhibition of cellular thioredoxin reductase by diaziquone and doxorubicin: Relationship to the inhibition of cell proliferation and decreased ribonucleotide reductase activity

Biochemical pharmacology, 1992-04, Vol.43 (7), p.1621-1626

1992

Link zum Volltext

Verfügbarkeit prüfen

Inhibition of cellular thioredoxin reductase by diaziquone and doxorubicin

Biochemical pharmacology, 1992-04, Vol.43 (7), p.1621-1626

1992

Link zum Volltext

Verfügbarkeit prüfen

1 – 11 von 11

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(10)
Mit Volltextzugriff
(10)

Publikationsform

Artikel
(11)

Sprache

Englisch
(11)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(10)
Science & Technology
(10)
Humans
(6)
Animals
(4)
Male
(4)
Pharmacology & Pharmacy
(4)
Aged
(3)
Antineoplastic Agents - Pharmacology
(3)
Biological And Medical Sciences
(3)
Cell Biology
(3)
Female
(3)
Medical Sciences
(3)
Middle Aged
(3)
Thioredoxin-Disulfide Reductase - Antagonists & Inhibitors
(3)
Adult
(2)
Aged, 80 And Over
(2)
Amino Acid Sequence
(2)
Aziridines - Pharmacology
(2)
Benzoquinones - Pharmacology
(2)
Biochemistry & Molecular Biology
(2)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Analysis of CD117-negative gastrointestinal stromal tumors

PIK3CA Exon 20 Mutation is Independently Associated with a Poor Prognosis in Breast Cancer Patients

Identification of Human-Specific Adaptation Sites of ATP6

ND4 mutation in transitional cell carcinoma: Does mitochondrial mutation occur before tumorigenesis?

Mechanism-based inhibition of thioredoxin reductase by antitumor quinoid compounds

Analysis of disease-associated ND4 mutations: how do we know which mutation is pathogenic?

Compliance of Clinical Trial Consent Forms with International Guidelines: Analysis of Deficiencies

What Type of Pivotal Study Design is Appropriate for an Investigational New Drug to Manage Chronic Angle Closure Glaucoma: Active Control or Placebo?

Inhibition Of Thioredoxin Reductase (E.C. 1.6.4.5.) By Antitumor Quinones

Inhibition of cellular thioredoxin reductase by diaziquone and doxorubicin: Relationship to the inhibition of cell proliferation and decreased ribonucleotide reductase activity

Inhibition of cellular thioredoxin reductase by diaziquone and doxorubicin

Suchergebnisse filtern